106 related articles for article (PubMed ID: 12065288)
1. Modulatory effects of estrogen in two murine models of experimental colitis.
Verdú EF; Deng Y; Bercik P; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G27-36. PubMed ID: 12065288
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
Ghia JE; Blennerhassett P; El-Sharkawy RT; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G711-8. PubMed ID: 17673544
[TBL] [Abstract][Full Text] [Related]
3. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
4. Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus.
Ghia JE; Galeazzi F; Ford DC; Hogaboam CM; Vallance BA; Collins S
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G770-7. PubMed ID: 18202111
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice.
Hans W; Schölmerich J; Gross V; Falk W
Eur Cytokine Netw; 2000 Mar; 11(1):67-74. PubMed ID: 10705301
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
Kwon KH; Murakami A; Hayashi R; Ohigashi H
Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
[TBL] [Abstract][Full Text] [Related]
8. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Matos I; Bento AF; Marcon R; Claudino RF; Calixto JB
Mol Immunol; 2013 Jul; 54(3-4):482-92. PubMed ID: 23454360
[TBL] [Abstract][Full Text] [Related]
9. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Katada K; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Watabe J; Yoshida N; Okanoue T; Yoshikawa T
J Nutr Biochem; 2006 Jun; 17(6):402-9. PubMed ID: 16214331
[TBL] [Abstract][Full Text] [Related]
10. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
11. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
12. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
Hyun E; Andrade-Gordon P; Steinhoff M; Vergnolle N
Gut; 2008 Sep; 57(9):1222-9. PubMed ID: 18460552
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
16. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
Ghia JE; Blennerhassett P; Kumar-Ondiveeran H; Verdu EF; Collins SM
Gastroenterology; 2006 Oct; 131(4):1122-30. PubMed ID: 17030182
[TBL] [Abstract][Full Text] [Related]
17. Physiological stress exacerbates murine colitis by enhancing proinflammatory cytokine expression that is dependent on IL-18.
Matsunaga H; Hokari R; Ueda T; Kurihara C; Hozumi H; Higashiyama M; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Sekiyama A; Miura S
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G555-64. PubMed ID: 21719737
[TBL] [Abstract][Full Text] [Related]
18. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
[TBL] [Abstract][Full Text] [Related]
19. A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat.
Fries W; Mazzon E; Sturiale S; Giofré MR; Lo Presti MA; Cuzzocrea S; Campo GM; Caputi AP; Longo G; Sturniolo GC
Life Sci; 2004 Apr; 74(22):2749-56. PubMed ID: 15043989
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
